Search

Your search keyword '"Maryann Kwa"' showing total 2 results
Start Over Author "Maryann Kwa" Publisher elsevier bv
2 results on '"Maryann Kwa"'

1. Metaplastic breast cancers: Genomic profiling, mutational burden and tumor-infiltrating lymphocytes

Author

Elad Sharon, Jessica Taff, Jeffrey S. Ross, James Suh, Maryann Kwa, Razelle Kurzrock, Nhu Ngo, Sylvia Adams, Andrea B. Troxel, Young Kwang Chae, Carsten Denkert, Sandip Pravin Patel, Nancy Tray, and Baljit Singh

Subjects
Poor prognosis, Genomic profiling, DNA Mutational Analysis, Triple Negative Breast Neoplasms, 03 medical and health sciences, 0302 clinical medicine, Immune system, Breast cancer, Biomarkers, Tumor, Humans, Medicine, 030212 general & internal medicine, Triple negative, Tumor-infiltrating lymphocytes, business.industry, Gene Expression Profiling, Immunogenicity, General Medicine, medicine.disease, Tumor Burden, 030220 oncology & carcinogenesis, Potential biomarkers, Cancer research, Female, Surgery, Tumor Suppressor Protein p53, business
Abstract

Metaplastic breast cancer (MPBC) is a rare subtype that accounts for

Published
2019
Full Text
View/download PDF

2. Pegylated liposomal doxorubicin and renal thrombotic microangiopathy: an under-recognized complication of prolonged treatment for ovarian cancer

Author

Linda Shavit, Franco M. Muggia, Maryann Kwa, Alberto Gabizon, Itzchak Slotki, and Meyer Lifschitz

Subjects
medicine.medical_specialty, Thrombotic microangiopathy, business.industry, urologic and male genital diseases, medicine.disease, Malignancy, Gastroenterology, female genital diseases and pregnancy complications, Pegylated Liposomal Doxorubicin, Surgery, Nephrology, Internal medicine, medicine, Complication, business, Ovarian cancer, Glomerular diseases, Prolonged treatment
Abstract

To the Editor: Jhaveri et al.1 provide a comprehensive review of glomerular diseases seen with malignancy and its treatments, including chemotherapy-induced thrombotic microangiopathy (TMA). However, they have overlooked evidence for renal TMA after pegylated liposomal doxorubicin (PLD) for ovarian cancer.

Published
2014
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results